Lilly closes $180M deal for Alnara Pharmaceuticals – BusinessWeek
By Dr. Matthew Watson
 The Money Times | Lilly closes $180M deal for Alnara Pharmaceuticals BusinessWeek Eli Lilly & Co. said it completed the acquisition of Alnara Pharmaceuticals Inc., a biotechnology company that is developing enzyme therapies. ... Lilly Closes Alnara AcquisitionInside INdiana Business (press release) |
Uncategorized
Comments Off on Lilly closes $180M deal for Alnara Pharmaceuticals – BusinessWeek |
July 22nd, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research